Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-07-21

Clinical Trial Update: Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of valdecoxib compared with naproxen for the signs and symptoms of rheumatoid arthritis in patients with severe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen (Naproxen)
  • Valdecoxib (valdecoxib)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED